BAYN.F (BAYN.F) News
Follow BAYN.F (BAYN.F) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Fitch Affirms Bayer Rating, Negative Outlook Amid Near-term Uncertainties
() -- Fitch Ratings affirmed its long-term issuer default rating on Bayer (BAYN.F) at BBB with a negative outlook. The rating agency said Monday the negative outlook reflects uncertainties regarding the German life scien
RATES | Jul 14, 2026, 08:58 AM UTC
H
Berenberg: Bayer Legal Victories Clear Path for Potential Crop Science Split; Price Target Up
() -- Berenberg raised its price target for Bayer (BAYN.F) to 55 euros from 40.50 euros, with an unchanged hold rating, noting recent legal wins have created a path for an "amicable" spin-off of its crop science division
EARNINGS | Jul 08, 2026, 06:22 AM UTC
L
AlphaValue/Baader Europe Downgrades Bayer to Reduce, Lifts PT
() -- AlphaValue/Baader Europe on Friday downgraded German pharmaceutical company Bayer (BAYN.F) to reduce from add and increased its price target to 53.30 euros from 52.30 euros. ( covers equity, commodity and economic
EQUITY | Jul 03, 2026, 12:35 PM UTC
L
Deutsche Bank Upgrades Bayer to Buy After US Supreme Court Ruling Lifts Litigation Overhang
() -- Deutsche Bank Research upgraded its investment opinion on Bayer (BAYN.F) following the recent US Supreme Court ruling that should contain the company's multi-billion-dollar glyphosate litigation. "Last week's Supre
EARNINGS | Jul 03, 2026, 08:46 AM UTC